Organigram Q3 EPS Lifted by Alliance Global Partners

Organigram Holdings Inc. (NASDAQ:OGI) – Investment analysts at Alliance Global Partners boosted their Q3 2025 earnings estimates for shares of Organigram in a report released on Tuesday, February 11th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings of ($0.02) per share for the quarter, up from their previous forecast of ($0.03). The consensus estimate for Organigram’s current full-year earnings is ($0.09) per share. Alliance Global Partners also issued estimates for Organigram’s Q4 2025 earnings at ($0.02) EPS, FY2025 earnings at ($0.18) EPS and FY2026 earnings at ($0.06) EPS.

Organigram Stock Down 5.9 %

Shares of Organigram stock opened at $1.27 on Friday. Organigram has a twelve month low of $1.27 and a twelve month high of $2.91. The company has a 50-day simple moving average of $1.56 and a two-hundred day simple moving average of $1.66. The stock has a market capitalization of $160.22 million, a price-to-earnings ratio of -3.34 and a beta of 1.00.

Organigram (NASDAQ:OGI) last issued its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%.

Hedge Funds Weigh In On Organigram

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Oxford Asset Management LLP acquired a new position in shares of Organigram in the 4th quarter valued at approximately $50,000. Two Sigma Securities LLC acquired a new position in shares of Organigram in the 4th quarter valued at approximately $26,000. Dimensional Fund Advisors LP raised its position in shares of Organigram by 13.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company’s stock valued at $579,000 after buying an additional 43,721 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of Organigram by 2.4% in the 4th quarter. Renaissance Technologies LLC now owns 914,648 shares of the company’s stock valued at $1,473,000 after buying an additional 21,200 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new position in Organigram during the 4th quarter worth approximately $1,153,000. 34.63% of the stock is currently owned by institutional investors and hedge funds.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.